AI Content Strategy
Governed, extractable content.
Health queries are among the most heavily filtered in both search and AI answers, and both weight demonstrable expertise over marketing.
Named, qualified authors with verifiable credentials materially affect both ranking and whether a model treats a page as a citable source.
Unattributed health content is discounted and largely ignored by retrieval.
Being cited as a reference is the realistic win, not being recommended as a provider.
Content queues stall for months waiting on review that was never scheduled.
Most journeys begin with a condition or symptom, not a provider name.
Visibility on condition questions is what puts you in the consideration set.
Credentials are checked by algorithms and by patients.
They redirect to clinical guidance rather than name providers.
Almost all of the failures trace to treating medical content as marketing content.
Health pages published without a named clinical author are discounted by search engines and ignored by retrieval pipelines.
Clinician bylines and review dates: Every substantive page carries a named, credentialed author and a visible review cycle.
Confident language about results attracts regulatory attention and removes you from citable sources.
Evidence-bounded copy: Claims kept inside what published evidence supports, with sources visible on the page.
Analytics and ad tooling on patient journeys creates exposure nobody reviewed.
Privacy-reviewed measurement: Tracking scoped with your compliance team before deployment.
Queues stall waiting for a review that was never scheduled.
Review capacity agreed up front: A named clinical reviewer and a realistic monthly volume set before commissioning.
The same five phases we run for every client, with the vertical detail set out at each one. The full model is on our methodology page.
Baseline plus an authorship, review and measurement-privacy audit. Unattributed health content is the most common finding.
Whether the constraint is clinical attribution, technical health, or that models defer to institutional sources and have no reason to reach for you.
A roadmap agreed with your compliance team, including a named clinical reviewer and a monthly review volume that is achievable.
Credentials and schema first, then condition and service content written, clinically reviewed and published within the agreed governance.
Condition-level visibility and citation as a reference source, tracked alongside the review pipeline, because one gates the other.
Reporting that tracks clinical governance alongside visibility, because one gates the other.
Presence on the symptom and condition queries that matter.
Where models and health surfaces credit your content.
Drafted, in review, cleared, published.
Credential coverage for your named clinicians.
Schema validity plus consent issues found.
Content priorities and required reviewer capacity.
Governed, extractable content.
Practitioner and organisation records.
Clinical source presence.
For anything substantive, yes. Unattributed health content is discounted in ranking and largely ignored by retrieval. A named, credentialed author is closer to a prerequisite than an enhancement.
Usually not directly. They favour institutional sources and general guidance. The achievable outcome is being one of the sources they draw on.
Tracking is scoped with your compliance team before deployment. We will not recommend instrumentation your privacy team has not reviewed.
Less than teams fear, but it must be scheduled. A few hours a month of structured review is usually enough; unscheduled review is the most common cause of a stalled healthcare programme.